2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 8.728.185 | 476.000 | 1 | ||
2020 | 0 | 11.381.970 | 505.000 | 1 | ||
2019 | 0 | 10.999.316 | 288.750 | 1 |
Total number of partners: 73
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 73
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-01-01 | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy | T2EVOLVE | participant | 8.728.185 | 29 |
2020-10-01 | The RapiD and SecuRe AI enhAnced DiaGnosis, Precision Medicine and Patient EmpOwerment Centered Decision Support System for Coronavirus PaNdemics | DRAGON | participant | 11.381.970 | 19 |
2019-12-01 | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies | imSAVAR | participant | 10.999.316 | 28 |